Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism

Bruni-Fitzgerald, 2015, Venous thromboembolism: an overview, J Vasc Nurs., 33, 95, 10.1016/j.jvn.2015.02.001

Lippi, 2020, Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis, Clin Chim Acta, 506, 145, 10.1016/j.cca.2020.03.022

Lippi, 2019, D-dimer is associated with severity of coronavirus disease

Tang, 2020, Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, J Thromb Haemost., 18, 1094, 10.1111/jth.14817

Klok, 2020, Incidence of thrombotic complications in critically ill ICU patients with COVID-19, Thromb Res.

Llitjos, 2020, High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients, J Thromb Haemost., 10.1111/jth.14869

Zhang, 2020, Coagulopathy and antiphospholipid antibodies in patients with covid-19, N Engl J Med., 382, 10.1056/NEJMc2007575

Harzallah, 2020, Lupus anticoagulant is frequent in patients with Covid-19, J Thromb Haemost.

Lodigiani, 2020

Poissy, 2020, Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence, Circulation., 10.1161/CIRCULATIONAHA.120.047430